CABOTEGRAVIR

UNII:	HMH0132Z1Q
Formula:	C₁₉H₁₇F₂N₃O₅
Preferred Substance Name:	CABOTEGRAVIR
InChIKey:	WCWSTNLSLKSJPK-LKFCYVNXSA-N

1051375-10-0
(3S,11AR)-N-((2,4-DIFLUOROPHENYL)METHYL)-6-HYDROXY-3-METHYL-5,7-DIOXO-2,3,5,7,11,11A-HEXAHYDROOXAZOLO(3,2-A)PYRIDO(1,2-D)PYRAZINE-8-CARBOXAMIDE
APRETUDE
CABENUVA COMPONENT CABOTEGRAVIR
CABOTEGRAVIR [INN]
CABOTEGRAVIR [JAN]
CABOTEGRAVIR [ORANGE BOOK]
CABOTEGRAVIR [USAN]
CABOTEGRAVIR [WHO-DD]
GSK1265744
GSK-1265744
GSK1265744A
GSK-1265744A
GSK744
OXAZOLO(3,2-A)PYRIDO(1,2-D)PYRAZINE-8-CARBOXAMIDE, N-((2,4-DIFLUOROPHENYL)METHYL)-2,3,5,7,11,11A-HEXAHYDRO-6-HYDROXY-3-METHYL-5,7-DIOXO-, (3S,11AR)-
S-265744

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CABOTEGRAVIR

Synonyms and Mappings

Resources